A citation-based method for searching scientific literature

Rui Wang, Haichuan Hu, Yunjian Pan, Yuan Li, Ting Ye, Chenguang Li, Xiaoyang Luo, Lei Wang, Hang Li, Yang Zhang, Fei Li, Yongming Lu, Qiong Lu, Jie Xu, David Garfield, Lei Shen, Hongbin Ji, William Pao, Yihua Sun, Haiquan Chen. J Clin Oncol 2012
Times Cited: 360



A Drilon, I Bergagnini, L Delasos, J Sabari, K M Woo, A Plodkowski, L Wang, M D Hellmann, P Joubert, C S Sima, R Smith, R Somwar, N Rekhtman, M Ladanyi, G J Riely, M G Kris. Ann Oncol 2016
Times Cited: 68




List of shared articles



Times cited

The Treatment Status of Patients in NSCLC With RET Fusion Under the Prelude of Selective RET-TKI Application in China: A Multicenter Retrospective Research.
Yan Meng, Yilin Yang, Yujia Fang, Xinqing Lin, Xiaohong Xie, Haiyi Deng, Jianhui Wu, Maolin Zhou, Ni Sun, Zhanhong Xie,[...]. Front Oncol 2022
1

Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas.
Lorenzo Belluomini, Alice Avancini, Luca Pasqualin, Jessica Insolda, Marco Sposito, Jessica Menis, Daniela Tregnago, Ilaria Trestini, Miriam Grazia Ferrara, Emilio Bria,[...]. Expert Rev Anticancer Ther 2022
1

Non-small-cell lung cancer: how to manage RET-positive disease.
Elisa Andrini, Mirta Mosca, Linda Galvani, Francesca Sperandi, Biagio Ricciuti, Giulio Metro, Giuseppe Lamberti. Drugs Context 2022
1

RET rearrangements in non-small cell lung cancer: Evolving treatment landscape and future challenges.
Alberto Servetto, Daniela Esposito, Roberto Ferrara, Diego Signorelli, Stefania Belli, Fabiana Napolitano, Antonio Santaniello, Paola Ciciola, Luigi Formisano, Roberto Bianco. Biochim Biophys Acta Rev Cancer 2022
0

Complete, Unpredictable, Multi-site Response Including Brain and Liver Metastases in a Patient With RET-rearranged Non-small-cell Lung Cancer Treated With Single-agent Immunotherapy: A Case Report.
Mariona Riudavets, Caroline Caramella, Pauline Pradere, Charles Naltet, Cécile Le Pechoux, Julien Adam, Laurence Mabille, Etienne Rouleau, Benjamin Besse, David Planchard. Clin Lung Cancer 2021
3

Targeting Infrequent Driver Alterations in Non-Small Cell Lung Cancer.
Marie-Julie Nokin, Chiara Ambrogio, Ernest Nadal, David Santamaria. Trends Cancer 2021
6


[Research Progress of Fusion Genes RET in Non-small Cell Lung Cancer].
Yujun Zheng, Wei Jiang, Dongyan Chen, Yanjun Li, Lulu Dai, Lei Huang, Mingji Wang. Zhongguo Fei Ai Za Zhi 2021
0


Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program.
Oliver Illini, Maximilian Johannes Hochmair, Hannah Fabikan, Christoph Weinlinger, Amanda Tufman, Aurélie Swalduz, Kristina Lamberg, Sayed M S Hashemi, Florian Huemer, Anders Vikström,[...]. Ther Adv Med Oncol 2021
7

Precision therapy for RET-altered cancers with RET inhibitors.
Kyaw Z Thein, Vamsidhar Velcheti, Blaine H M Mooers, Jie Wu, Vivek Subbiah. Trends Cancer 2021
21


Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practice.
Jiyun Lee, Bo Mi Ku, Joon Ho Shim, Yoon La Choi, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn. Jpn J Clin Oncol 2020
11

Association Between RET Fusions and Efficacy of Pemetrexed-based Chemotherapy for Patients With Advanced NSCLC in China: A Multicenter Retrospective Study.
Tianle Shen, Xingxiang Pu, Liping Wang, Zongyang Yu, Jinluan Li, Yinbin Zhang, Xianbin Liang, Huafei Chen, Chunwei Xu, Zhengbo Song,[...]. Clin Lung Cancer 2020
11

New Targets in Lung Cancer (Excluding EGFR, ALK, ROS1).
Alessandro Russo, Ana Rita Lopes, Michael G McCusker, Sandra Gimenez Garrigues, Giuseppina R Ricciardi, Katherine E Arensmeyer, Katherine A Scilla, Ranee Mehra, Christian Rolfo. Curr Oncol Rep 2020
27